-
1
-
-
0842263981
-
The biology of peroxisome proliferator-activated receptors: Relationship with lipid metabolism and insulin sensitivity
-
Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 2004; 153 (1):S43-S50.
-
(2004)
Diabetes
, vol.153
, Issue.1
-
-
Ferre, P.1
-
2
-
-
33644645013
-
PPAR delta: A dagger in the heart of the metabolic syndrome
-
Barish GD, Narkar VA, Evans RM. PPAR delta: a dagger in the heart of the metabolic syndrome. J Clin Invest 2006; 116:590-597.
-
(2006)
J Clin Invest
, vol.116
, pp. 590-597
-
-
Barish, G.D.1
Narkar, V.A.2
Evans, R.M.3
-
3
-
-
3042634455
-
Peroxisome proliferator-activated receptor (PPAR) activation induces tissue-specific effects on fatty acid uptake and metabolism in vivo: A study using the novel PPAR alpha/gamma agonist tesaglitazar
-
Hegarty BD, Furler SM, Oakes ND, Kraegen EW, Cooney GJ. Peroxisome proliferator-activated receptor (PPAR) activation induces tissue-specific effects on fatty acid uptake and metabolism in vivo: a study using the novel PPAR alpha/gamma agonist tesaglitazar. Endocrinology 2004; 145:3158-3164.
-
(2004)
Endocrinology
, vol.145
, pp. 3158-3164
-
-
Hegarty, B.D.1
Furler, S.M.2
Oakes, N.D.3
Kraegen, E.W.4
Cooney, G.J.5
-
4
-
-
33644783769
-
Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice
-
Harrity T, Farrelly D, Tieman A, Chu C, Kunselman L, Gu L, et al. Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice. Diabetes 2006; 55:240-248.
-
(2006)
Diabetes
, vol.55
, pp. 240-248
-
-
Harrity, T.1
Farrelly, D.2
Tieman, A.3
Chu, C.4
Kunselman, L.5
Gu, L.6
-
5
-
-
33745957332
-
Improvement of glycemic control, trigtycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazonecomparative study
-
Kendall DM, Rubin CJ, Mohideen P, Ledeine JM, Bolder R, Gross J, et al. Improvement of glycemic control, trigtycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a double-blind, randomized, pioglitazonecomparative study. Diabetes Care 2006; 29:1016-1023.
-
(2006)
Diabetes Care
, vol.29
, pp. 1016-1023
-
-
Kendall, D.M.1
Rubin, C.J.2
Mohideen, P.3
Ledeine, J.M.4
Bolder, R.5
Gross, J.6
-
6
-
-
0346219290
-
Considerations for management of fluid dynamic issues associated with thiazolidinediones
-
Hollenberg NK. Considerations for management of fluid dynamic issues associated with thiazolidinediones. Am J Med 2003; 115 (Suppl 8A): 111S-115S.
-
(2003)
Am J Med
, vol.115
, Issue.SUPPL. 8A
-
-
Hollenberg, N.K.1
-
7
-
-
0344304678
-
Thiazolidinedione use, fluid retention, and congestive heart failure: A consensus statement from the American Heart Association and American Diabetes Association
-
Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Circulation 2003; 108:2941-2948.
-
(2003)
Circulation
, vol.108
, pp. 2941-2948
-
-
Nesto, R.W.1
Bell, D.2
Bonow, R.O.3
Fonseca, V.4
Grundy, S.M.5
Horton, E.S.6
-
8
-
-
0041778253
-
Thiazolidinedione-associated congestive heart failure and pulmonary edema
-
Kermani A, Garg A. Thiazolidinedione-associated congestive heart failure and pulmonary edema. Mayo din Proc 2003; 78:1088-1091.
-
(2003)
Mayo din Proc
, vol.78
, pp. 1088-1091
-
-
Kermani, A.1
Garg, A.2
-
9
-
-
21544479710
-
Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention
-
Zhang H, Zhang A, Kohan DE, Nelson RD, Gonzalez FJ, Yang T. Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention. Proc Natl Acad Sci U S A 2005; 102:9406-9411.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 9406-9411
-
-
Zhang, H.1
Zhang, A.2
Kohan, D.E.3
Nelson, R.D.4
Gonzalez, F.J.5
Yang, T.6
-
10
-
-
23844472901
-
Thiazolidinediones expand body fluid volume through PPAR gamma stimulation of ENaC-mediated renal salt absorption
-
Guan Y, Hao C. Cha DR, Rao R, Lu W, Kohan DE, et al. Thiazolidinediones expand body fluid volume through PPAR gamma stimulation of ENaC-mediated renal salt absorption. Nat Med 2005; 11:861-866.
-
(2005)
Nat Med
, vol.11
, pp. 861-866
-
-
Guan, Y.1
Hao, C.2
Cha, D.R.3
Rao, R.4
Lu, W.5
Kohan, D.E.6
-
11
-
-
0034917719
-
Highthroughput genotyping with single nucleotide polymorphisms
-
Ranade K, Chang MS, Ting CT, Pei D, Hsiao CF, Olivier M, et al. Highthroughput genotyping with single nucleotide polymorphisms. Genome Res 2001; 11:1262-1268.
-
(2001)
Genome Res
, vol.11
, pp. 1262-1268
-
-
Ranade, K.1
Chang, M.S.2
Ting, C.T.3
Pei, D.4
Hsiao, C.F.5
Olivier, M.6
-
12
-
-
21244494825
-
Strong association of a renin intronic dimorphism with essential hypertension
-
Ahmad U, Saleheen D, Bokhari A, Frossard PM. Strong association of a renin intronic dimorphism with essential hypertension. Hypertens Res 2005; 28:339-344.
-
(2005)
Hypertens Res
, vol.28
, pp. 339-344
-
-
Ahmad, U.1
Saleheen, D.2
Bokhari, A.3
Frossard, P.M.4
-
13
-
-
0032895749
-
The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people
-
Tiret L, Poirier O, Hallet V, McDonagh TA, Morrison C, McMurray JJ, et al. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 1999; 33:1169-1174.
-
(1999)
Hypertension
, vol.33
, pp. 1169-1174
-
-
Tiret, L.1
Poirier, O.2
Hallet, V.3
McDonagh, T.A.4
Morrison, C.5
McMurray, J.J.6
-
14
-
-
0033617342
-
A gain-of-function polymorphism in a G-protem coupling domain of the human betaladrenergrc receptor
-
Mason DA, Moore JD, Green SA, Liggett SB. A gain-of-function polymorphism in a G-protem coupling domain of the human betaladrenergrc receptor. J Biol Chem 1999; 274:12670-12674.
-
(1999)
J Biol Chem
, vol.274
, pp. 12670-12674
-
-
Mason, D.A.1
Moore, J.D.2
Green, S.A.3
Liggett, S.B.4
-
15
-
-
0037385575
-
A common beta 1-adrenergic receptor polymorphism (Arg389Gry) affects blood pressure response to beta-blockade
-
Sofowora GG, Dishy V, Muazkat M, Xie HG, Kim RB, Harris PA, et al. A common beta 1-adrenergic receptor polymorphism (Arg389Gry) affects blood pressure response to beta-blockade. Clin Pharmacol Ther 2003; 73:366-371.
-
(2003)
Clin Pharmacol Ther
, vol.73
, pp. 366-371
-
-
Sofowora, G.G.1
Dishy, V.2
Muazkat, M.3
Xie, H.G.4
Kim, R.B.5
Harris, P.A.6
-
16
-
-
0038772374
-
Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol
-
Johnson JA, Zneh I, Puckett BJ, McGorray SP, Yarandi HN, Pauly DF. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther 2003; 74:44-52.
-
(2003)
Clin Pharmacol Ther
, vol.74
, pp. 44-52
-
-
Johnson, J.A.1
Zneh, I.2
Puckett, B.J.3
McGorray, S.P.4
Yarandi, H.N.5
Pauly, D.F.6
-
17
-
-
0033520304
-
Peroxisome proliferator-activated receptor activators inhibit thrombininduced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway
-
Delerive P, Martin-Nizard F, Chinetti G, Trottein F, Fruchart JC, Najib J, et al. Peroxisome proliferator-activated receptor activators inhibit thrombininduced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circ Res 1999; 85: 394-402.
-
(1999)
Circ Res
, vol.85
, pp. 394-402
-
-
Delerive, P.1
Martin-Nizard, F.2
Chinetti, G.3
Trottein, F.4
Fruchart, J.C.5
Najib, J.6
-
18
-
-
0031589185
-
Regulation of human renin secretion and gene transcription in Calu-6 cells
-
Germain S, Philippe J, Fuchs S, Lengronne A, Corvol P, Pinet F. Regulation of human renin secretion and gene transcription in Calu-6 cells. FEBS Lett 1997; 407:177-183.
-
(1997)
FEBS Lett
, vol.407
, pp. 177-183
-
-
Germain, S.1
Philippe, J.2
Fuchs, S.3
Lengronne, A.4
Corvol, P.5
Pinet, F.6
-
19
-
-
0028900531
-
Endogenous human renin expression and promoter activity in Calu-6, a pulmonary carcinoma cell line
-
Lang JA, Yang G, Kern JA, Sigmund CD. Endogenous human renin expression and promoter activity in Calu-6, a pulmonary carcinoma cell line. Hypertension 1995; 25:704-710.
-
(1995)
Hypertension
, vol.25
, pp. 704-710
-
-
Lang, J.A.1
Yang, G.2
Kern, J.A.3
Sigmund, C.D.4
-
20
-
-
35848935619
-
Peroxisome proliferator-activated receptor-gamma is involved in the control of renin gene expression
-
Todorov VT, Desch M, Schmitt-Nilson N, Todorova A, Kurtz A. Peroxisome proliferator-activated receptor-gamma is involved in the control of renin gene expression. Hypertension 2007; 50:939-944.
-
(2007)
Hypertension
, vol.50
, pp. 939-944
-
-
Todorov, V.T.1
Desch, M.2
Schmitt-Nilson, N.3
Todorova, A.4
Kurtz, A.5
-
22
-
-
0012182716
-
-
Izzo J, Black HR, editors, Philadelphia: Lippincott Williams & Williams;
-
Izzo J, Black HR, editors. Hypertension primer. Philadelphia: Lippincott Williams & Williams; 1993.
-
(1993)
Hypertension primer
-
-
-
23
-
-
0031459195
-
Beta-adrenergic stimulation of renin expression in vivo
-
Holmer SR, Kaissling B, Putnik K, Pfeifer M, Kramer BK, Riegger GA, et al. Beta-adrenergic stimulation of renin expression in vivo. J Hypertens 1997; 15:1471-1479.
-
(1997)
J Hypertens
, vol.15
, pp. 1471-1479
-
-
Holmer, S.R.1
Kaissling, B.2
Putnik, K.3
Pfeifer, M.4
Kramer, B.K.5
Riegger, G.A.6
-
24
-
-
0036889540
-
Endothelin-1 increases calcium and attenuates renin gene expression in As4.1 cells
-
Ryan MJ, Black TA, Millard SL, Gross KW, Hajduczok G. Endothelin-1 increases calcium and attenuates renin gene expression in As4.1 cells. Am Physiol Heart Circ Physiol 2002; 283:H2458-H2465.
-
(2002)
Am Physiol Heart Circ Physiol
, vol.283
-
-
Ryan, M.J.1
Black, T.A.2
Millard, S.L.3
Gross, K.W.4
Hajduczok, G.5
-
25
-
-
1642302410
-
Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men
-
Zanchi A, Chiolero A, Maillard M, Nussberger J, Brunner HR, Burner M. Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men. J Clin Endocrinol Metab 2004; 89:1140-1145.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 1140-1145
-
-
Zanchi, A.1
Chiolero, A.2
Maillard, M.3
Nussberger, J.4
Brunner, H.R.5
Burner, M.6
|